On air · 1 of 3 networks
Bora Pharmaceuticals
- boracdmo.com
- Healthcare & Life Sciences
- TW
- 765 employees
Bora Pharmaceuticals’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 223. Watch Bora Pharmaceuticals with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 195 | Checked 28 Oct 2026 | See all 223 ads → | ||
| Meta | Not checked | — | |||
| Recently | 33 | Ads on the Google Ads Transparency Center | Checked 14 Oct 2026 | Collect them with the API → |
Bora Pharmaceuticals has 195 live LinkedIn ads. We recorded 33 Google ads on 14 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 19 Dec 2025
📖 𝐍𝐞𝐰 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: “𝐅𝐨𝐫 𝐭𝐡𝐞 𝐋𝐨𝐯𝐞 𝐨𝐟 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬: 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐞.” Our CDMO Division President, J.D. Mowery, was recently published in The Medicine Maker with a byline titled “For the Love of Patients: Communicate.” In the article, J.D. explores what truly defines a strong CDMO–sponsor partnership, emphasizing that success goes beyond capabilities and infrastructure. Clear communication, mutual trust, and shared accountability are essential to keeping programs on track and, ultimately, delivering medicines to patients. At Bora, this philosophy guides how we work with our partners every day. From early development through commercial manufacturing, we believe transparent collaboration and aligned priorities are critical to achieving reliably on-time and in-full outcomes. Read the full article here ➡️ https://lnkd.in/eqShxsQZ #CDMO #PharmaManufacturing #PatientCentricity #Quality #Partnership #Leadership
- LINKEDIN · VIDEOSince 4 Dec 2025
🎙️𝐍𝐨𝐰 𝐋𝐢𝐯𝐞: 𝐉.𝐃. 𝐌𝐨𝐰𝐞𝐫𝐲 𝐨𝐧 𝑴𝒂𝒌𝒊𝒏𝒈 𝒊𝒕 𝒊𝒏 𝑴𝒂𝒏𝒖𝒇𝒂𝒄𝒕𝒖𝒓𝒊𝒏𝒈 Season 2 of Making it in Manufacturing, a podcast powered by ARTO, opens with our very own CDMO Division President, J.D. Mowery. With 25+ years of industry experience, J.D. brings deep operational expertise and a global perspective to this discussion on where the industry is headed. For this episode, J.D. sat down with host Thomas McMann while at CPHI Frankfurt to discuss: • Smart integration and scaling following acquisitions • Why quality remains the sharpest competitive advantage • What it means to partner with purpose in today’s pharma landscape • The future of CDMOs — and how AI is shaping that evolution For leaders across pharma and biotech, this is a conversation packed with insight, clarity, and practical takeaways you’ll want your teams to hear. Big thank you to the Making it in Manufacturing team for having us. 🎧 𝐋𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐨𝐧 𝐲𝐨𝐮𝐫 𝐩𝐫𝐞𝐟𝐞𝐫𝐫𝐞𝐝 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦: https://lnkd.in/dqTBAshA #BoraPharmaceuticals #CDMO #PharmaManufacturing #Leadership #OperationalExcellence #DrugDevelopment
- LINKEDIN · IMAGESince 2 Dec 2025
This December marks a major milestone for our Mississauga, Ontario, Canada site: 5 years of serving our partners as part of the Bora Pharmaceuticals network. 🎉 As we celebrate this anniversary, we’re honored to share a message from one of our valued customers — a reflection of the team’s hard work and commitment: “Congratulations on your 5-year anniversary! … We continue to be impressed by the team’s work ethic and the quality of the work delivered. Wishing you many more years of success and to our continued partnership.” — US Medical Dermatology Company Thank you to our Mississauga colleagues for making feedback like this possible and to our partners for trusting us over the past five years. Follow along as we celebrate this milestone all month long with employee spotlights and more. #BoraPharmaceuticals #Mississauga #Anniversary #CDMO #PharmaManufacturing #Partnership
- LINKEDIN · IMAGESince 26 Nov 2025
𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭𝐢𝐧𝐠 𝐟𝐫𝐞𝐬𝐡 𝐩𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐭𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐭𝐞𝐚𝐦 Two of our Bora Pharmaceuticals subject matter experts, Judith Zamparo, Technical Manager, and Anant Patel, Technical Process Lead, contributed to a new Manufacturing Chemist article exploring what’s really driving commercial technology-transfer delays and how to prevent them. At Bora, we see technology transfer as a truly collaborative discipline, and their piece reflects that mindset. Judith and Anant further outline practical strategies sponsors can use to navigate common tech-transfer obstacles, emphasizing deeper process understanding, proactive supply management, and strong partnership readiness. 📰 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞𝐫𝐬 𝐜𝐚𝐧 𝐫𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: https://lnkd.in/gMa4mhsH For those without a subscription, we’re also sharing an additional resource: Bora’s own article, 𝘎𝘦𝘵𝘵𝘪𝘯𝘨 𝘵𝘰 𝘵𝘩𝘦 𝘏𝘦𝘢𝘳𝘵 𝘰𝘧 𝘊𝘋𝘔𝘖 𝘛𝘦𝘤𝘩 𝘛𝘳𝘢𝘯𝘴𝘧𝘦𝘳 𝘌𝘹𝘤𝘦𝘭𝘭𝘦𝘯𝘤𝘦, which expands on similar themes and provides a deeper look into our approach. 🔗 Download it here: https://lnkd.in/g7V9SNzz #TechTransfer #PharmaManufacturing #CDMO #BoraPharmaceuticals #ProcessExcellence #ManufacturingChemist
- LINKEDIN · IMAGESince 21 Nov 2025
🎙️𝐍𝐞𝐰 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 𝐅𝐞𝐚𝐭𝐮𝐫𝐞: 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐞 𝐭𝐨 𝐌𝐚𝐫𝐤𝐞𝐭 Jason Foss, Head of Corporate Development at Bora Pharmaceuticals, recently joined a distinguished panel on Molecule to Market, hosted by Raman Sehgal. In this conversation, Jason and fellow industry leaders reflect on the year and share what lies ahead for pharma services M&A. Here are a few of the themes explored: ● How market stabilization has been overtaken by the need for adaptation in times of uncertainty ● Disciplined and deeper M&A, with heightened scrutiny, buyer and seller disconnect, and a sharper focus on operational efficiency ● Why the “picks and shovels” that serve multiple modalities are where opportunity lies in pharma services ● The shifts and trends that could reshape pharma services in the years ahead 𝐋𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐡𝐞𝐫𝐞: 🎧 Apple: https://lnkd.in/ghMRVjSn 🎧 Spotify: https://lnkd.in/gsM-c4fZ #BoraPharmaceuticals #MoleculeToMarket #PharmaServices #CDMO #DrugDevelopment #LifeSciences #MergersAndAcquisitions
- LINKEDIN · IMAGESince 19 Nov 2025
𝗦𝗰𝗮𝗹𝗲 𝗨.𝗦. 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗕𝗼𝗿𝗮 In today’s landscape, having pharmaceutical manufacturing anchored in the U.S. matters—for regulatory alignment, cost efficiency, and supply security. Together, Bora Pharmaceuticals and Bora Biologics operate three U.S. facilities, providing reliable manufacturing at scale paired with our unmatched quality and dedication to customer service: 💉𝐁𝐚𝐥𝐭𝐢𝐦𝐨𝐫𝐞–𝐂𝐚𝐦𝐝𝐞𝐧, 𝐌𝐃: Sterile injectable fill/finish site with expertise in formulation, filling (vial and pre-filled syringe), inspection, packaging, labeling, and on-site testing of liquid and lyophilized sterile injectable drug products offering aseptic lines, lyophilization, vials, prefilled syringes, and formulation support. 💊𝐌𝐚𝐩𝐥𝐞 𝐆𝐫𝐨𝐯𝐞, 𝐌𝐍: Expanded oral solid dose, powder, and liquid manufacturing, complete with on-site development labs, QC, and high-throughput production capabilities. Expertise in solvent handling and DEA controlled drugs. 🧬𝐒𝐚𝐧 𝐃𝐢𝐞𝐠𝐨, 𝐂𝐀: Biologics drug substance hub with end-to-end biologics expertise, from formulation to delivery systems. Integration with Baltimore sterile fill/finish for seamless biologics scale-up. Secure your U.S. manufacturing slot now: https://lnkd.in/g5ZSXAiT #CDMO #Biologics #OralSolidDose #FillFinish #PharmaReliability #USManufacturing
6 of 223 adsSign up to see every Bora Pharmaceuticals ad, filter by format and date, and get alerts on new ones.
See all 223 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.